Visit Professional Section
 

Why we won’t sell student pods

by Robert Bence today
The advent of ABS’s and the current development in the Family Justice System provide a ripe environment for change in the world of family law. From my experience, the consumer almost always 3 key questions: What will be the outcome? How long will it take? How much will it cost?

Sterling lower on BoE Inflation Report

by Matt Williams today
Good morning. Auctions in the last few days have brought some big valuations. A painting by Mark Rothko called 'Orange, Red, Yellow' went for $87 million. A diamond known as Le Beau Sancy sold for eight million Swiss francs. But the real biggie goes on the block today; a social networking website called Facebook.

The hourly rate is dead, long live the fixed fee?

by Colin Mitchell today
The advent of ABS’s and the current development in the Family Justice System provide a ripe environment for change in the world of family law. From my experience, the consumer almost always 3 key questions: What will be the outcome? How long will it take? How much will it cost?

How is investment income taxed?

by Jaskarn Pawar today
There has been a lot of focus on investing for income over the past couple of years. This is mainly because income levels (yields) are generally down on where they were a few years ago. Dividends are lower because companies are generally seeing some tough times, and interest payments are lower from bonds and gilts as their prices have risen.

How coaching can help you achieve your goals

by Alison Whistler today
At B Legal we like to take a practical approach to the law and to consider a client’s goals and objectives rather than just providing legal advice. There are many occasions when we suggest to clients that other professionals may also be able to help them and I have talked in a previous blog about financial advice.

Can a management shake-up cure AstraZeneca?

Shareholder revolts have claimed the jobs of a handful of Britain’s most high profile bosses in the last couple of months, among them David Brennan, the chief executive of drugs giant AstraZeneca (LON:AZN). After six years in the role, Brennan is leaving under a cloud of concern about the drug giant’s ability...

Discover Total Investor

We are here to make your financial life easier, provide access to helpful information and content, discuss issues, create groups and seek assistance from thousands of multi-discipline professional members
Get Advice
Search and connect to thousands of legal, financial, accounting and property professional experts
Groups & Discussions
Share and discuss your experiences and issues in groups
Questions and Answers
Post and answer open questions to fellow members of the public and Pro's
News & Views
View and comment on expert info, blogs, articles, news and ideas
Resources
View and comment on useful expert guides, webTV & product info

Latest Video

 
Advertisement